These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7825467)

  • 1. A review: the active peptide of lactoferrin.
    Tomita M; Takase M; Bellamy W; Shimamura S
    Acta Paediatr Jpn; 1994 Oct; 36(5):585-91. PubMed ID: 7825467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial peptides of lactoferrin.
    Tomita M; Takase M; Wakabayashi H; Bellamy W
    Adv Exp Med Biol; 1994; 357():209-18. PubMed ID: 7762432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactoferricin derived from milk protein lactoferrin.
    Wakabayashi H; Takase M; Tomita M
    Curr Pharm Des; 2003; 9(16):1277-87. PubMed ID: 12769736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin.
    Bellamy W; Takase M; Wakabayashi H; Kawase K; Tomita M
    J Appl Bacteriol; 1992 Dec; 73(6):472-9. PubMed ID: 1490908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibacterial activity in bovine lactoferrin-derived peptides.
    Hoek KS; Milne JM; Grieve PA; Dionysius DA; Smith R
    Antimicrob Agents Chemother; 1997 Jan; 41(1):54-9. PubMed ID: 8980754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative antimicrobial activity and mechanism of action of bovine lactoferricin-derived synthetic peptides.
    Liu Y; Han F; Xie Y; Wang Y
    Biometals; 2011 Dec; 24(6):1069-78. PubMed ID: 21607695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation in antimicrobial activity of lactoferricin-derived peptides explained by structure modelling.
    Farnaud S; Patel A; Odell EW; Evans RW
    FEMS Microbiol Lett; 2004 Sep; 238(1):221-6. PubMed ID: 15336425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial activity of peptides homologous to a loop region in human lactoferrin.
    Odell EW; Sarra R; Foxworthy M; Chapple DS; Evans RW
    FEBS Lett; 1996 Mar; 382(1-2):175-8. PubMed ID: 8612745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-biological activity relationships of 11-residue highly basic peptide segment of bovine lactoferrin.
    Kang JH; Lee MK; Kim KL; Hahm KS
    Int J Pept Protein Res; 1996 Oct; 48(4):357-63. PubMed ID: 8919056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Killing of Candida albicans by lactoferricin B, a potent antimicrobial peptide derived from the N-terminal region of bovine lactoferrin.
    Bellamy W; Wakabayashi H; Takase M; Kawase K; Shimamura S; Tomita M
    Med Microbiol Immunol; 1993 May; 182(2):97-105. PubMed ID: 8332105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and Purification of the Main Component Contained in Camel Milk and Its Antimicrobial Activities Against Bacterial Plant Pathogens.
    Tanhaeian A; Shahriari Ahmadi F; Sekhavati MH; Mamarabadi M
    Probiotics Antimicrob Proteins; 2018 Dec; 10(4):787-793. PubMed ID: 29619665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the bactericidal domain of lactoferrin.
    Bellamy W; Takase M; Yamauchi K; Wakabayashi H; Kawase K; Tomita M
    Biochim Biophys Acta; 1992 May; 1121(1-2):130-6. PubMed ID: 1599934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-Acylated and D enantiomer derivatives of a nonamer core peptide of lactoferricin B showing improved antimicrobial activity.
    Wakabayashi H; Matsumoto H; Hashimoto K; Teraguchi S; Takase M; Hayasawa H
    Antimicrob Agents Chemother; 1999 May; 43(5):1267-9. PubMed ID: 10223949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-function relationship of antibacterial synthetic peptides homologous to a helical surface region on human lactoferrin against Escherichia coli serotype O111.
    Chapple DS; Mason DJ; Joannou CL; Odell EW; Gant V; Evans RW
    Infect Immun; 1998 Jun; 66(6):2434-40. PubMed ID: 9596699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial activity of multiple antigen peptides homologous to a loop region in human lactoferrin.
    Azuma M; Kojima T; Yokoyama I; Tajiri H; Yoshikawa K; Saga S; Del Carpio CA
    J Pept Res; 1999 Sep; 54(3):237-41. PubMed ID: 10517161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bactericidal kinetics of 3 lactoferricins against Staphylococcus aureus and Escherichia coli.
    Ulvatne H; Vorland LH
    Scand J Infect Dis; 2001; 33(7):507-11. PubMed ID: 11515760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A helical region on human lactoferrin. Its role in antibacterial pathogenesis.
    Chapple DS; Joannou CL; Mason DJ; Shergill JK; Odell EW; Gant V; Evans RW
    Adv Exp Med Biol; 1998; 443():215-20. PubMed ID: 9781361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-complement effects of lactoferrin-derived peptides.
    Samuelsen Ø; Haukland HH; Ulvatne H; Vorland LH
    FEMS Immunol Med Microbiol; 2004 Jun; 41(2):141-8. PubMed ID: 15145458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The medicinal chemistry of short lactoferricin-based antibacterial peptides.
    Haug BE; Strøm MB; Svendsen JS
    Curr Med Chem; 2007; 14(1):1-18. PubMed ID: 17266565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of lactoferrin on gram-negative bacteria.
    Ellison RT
    Adv Exp Med Biol; 1994; 357():71-90. PubMed ID: 7762448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.